logo Image
infectious diseases

Infectious diseases with high morbidity and mortality

Pneumonia
HIV/AIDS
Diarrhea
Tuberculosis
Malaria
Measles

INFECTIOUS DISEASES ARE MAJOR KILLERS IN DEVELOPING REGIONS of the world. Diseases that are prevented and treated quite readily in wealthier nations have a devastating effect on poor communities in Africa, Central America, and South America. Too often, the underlying problem is a simple lack of community-level systems for delivering health care and for providing clean water and adequate nutrition.

The Izumi Foundation supports projects that address six infectious diseases with high morbidity and mortality that have been identified by the World Health Organization. Of particular interest are projects that also promote maternal and child health and build community capacity. The foundation frequently lends its support to collaborative projects that promise to achieve national or regional impact.

subtitle imageprgrams
The Measles Initiative is a collaborative effort to reduce measles deaths globally. The foundation participates in the initiative through grants to the United Nations Foundation. Our support has helped with two efforts: upgrading the “vaccine cold chain,” or temperature-controlled vaccine supply system, throughout Mozambique, and supplying bednets that protect pregnant women and children under age five from malaria in Mali.

The Alliance for the Prudent Use of Antibiotics is addressing the growing problem of drug resistance in Africa by establishing chapters in Namibia, Tanzania, and the Gambia. By promoting the development of appropriate antimicrobial policy and practice, the three national chapters will help to ensure the future effectiveness of life-saving antibiotics.

The African Services Committee provides voluntary HIV testing and counseling, palliative care, and treatment at a clinic in the Tigray region of Ethiopia. This project is consistent with the foundation’s desire to devote its resources to providing cost-effective prevention and treatment activities to people at risk of and living with HIV, through support of replicable, community-based models.




infectious image 2